Biotech · Private company
Warner Chilcott
Track this companyFree. Adds Warner Chilcott to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- VehiclePhase 3 · Postmenopausal Vulvovaginal AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Vulvovaginal AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- WC3011 Estradiol Vaginal CreamPhase 3 · Postmenopausal Vulvovaginal AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- WC3011 Estradiol Vaginal CreamPhase 3 · Vulvovaginal AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- DarifenacinPhase 2 · Neurogenic Detrusor OveractivityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With DyspareuniaPHASE3 · COMPLETED · started Apr 12, 2013ClinicalTrials.gov NCT01845649 · fetched Nov 12, 2026
- Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal WomenPHASE3 · COMPLETED · started Jan 31, 2013ClinicalTrials.gov NCT01816139 · fetched Nov 12, 2026
- Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)PHASE3 · COMPLETED · started Oct 20, 2011ClinicalTrials.gov NCT01455597 · fetched Nov 12, 2026
- Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal WomenPHASE3 · COMPLETED · started Jun 29, 2011ClinicalTrials.gov NCT01400776 · fetched Nov 12, 2026
- A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor OveractivityPHASE2 · TERMINATED · started Oct 7, 2008ClinicalTrials.gov NCT00712322 · fetched Nov 12, 2026